Solutions
Xana-Bio offers life sciences innovators fast and comprehensive medical data annotations, empowering them to accelerate drug discovery and harness real-world evidence at an unprecedented scale.
Accelerating drug discovery and development with AI-enabled research and opportunity identification for approved therapies.
AI is increasingly used in drug discovery to understand disease mechanisms, and predict response rates.
Image analysis Multi-omics and clinical notes Intellectual property knowledge graph
From patient recruitment, to insights on current and past clinical trials, AI offers an opportunity to optimize trial design and success.
Predicting patient qualification Real world data analysis Reanalysis of failed clinical trials Patient subgroup identification
Big data and AI are being leveraged to better understand competitors, as well as HCP behaviors.
Improve HCP targeting Competitive analysis Patient identification Predicting adherenceXANA accelerates AI development with speedy access to millions of diverse data points. Rooted in quality, it ensures consistent performance, advanced insights, and top-notch privacy across various industries and data types.
Stop annotating data slowly with in-house teams or outsourcing to teams whose quality you can't control.
Access the Centaur Labs network of thousands of medical doctors, professionals, researchers and students for skilled annotation
You define quality. We rigorously measure and manage it.
Incentivize labeler performance with small batch, mobile-first competitions. Labelers are only paid for performance and give 100% of their effort on every case
Proactively understand the nuances of your dataset, so your data works with you, not against you.
Leverage case-level insights to inform model development e.g. precision-recall curves, label distribution, labeler agreement